Please assess the completion status of the following clinical trial:

Trial Title: Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18-23 year old college females who are planning to return to the university for the next fall semester.~Exclusion Criteria:~* Pregnancy or planned pregnancy.~* Prior receipt of HPV vaccine.~* Greater than four lifetime sexual partners.~* Immunosuppression.~* Anti-coagulant therapy.~* Breastfeeding.~* History of abnormal pap smear.~* Allergy to vaccine components.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 23 Years
- Healthy Volunteers: t

Study Arms:
- 6 mon. 3rd dose of quadrivalent human papillomavirus vaccine (Type: ACTIVE_COMPARATOR): Receipt of three doses of quadrivalent human papillomavirus vaccine according to the regular schedule of 0,2, and 6 months.
- 12 mon. 3rd dose of quadrivalent human papillomavirus vaccine (Type: ACTIVE_COMPARATOR): Receipt of three doses of quadrivalent human papillomavirus vaccine on a delayed schedule of 0,2, and 12 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).